Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

California-Based Biopharma Signs Licensing Deal for Acquired Asset

The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report. In May 21 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) signed a licensing d...
Streetwise Reports | May 27, 2019 |

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines

Translate Bio shares traded 45% higher reaching a new 52-week high after the company reported that it is expanding its collaboration with Sanofi Pasteur to develop mRNA vaccines across all infectious disease areas. Clinical-stage messenger RNA (mRNA) therapeutics c...
Streetwise Reports | June 24, 2020 |

Don’t Get Lulled to Sleep by the Tiny EUR/USD Moves

EUR/USD keeps testing the green support zone, yet the bears can’t muster enough strength to break through. What are their chances of breaking below before Thanksgiving, or is another rebound more likely actually? Although EUR/USD moved down a bit earli...
Nadia Simmons | November 28, 2019 |

Oil Sliding Faster Than You Can Blink

Crude oil futures declined sharply on Friday. The steep slide’s result was a breakdown below the lower border of the rising green trend channel. As the prices closed the day below the formation, it’s clearly a bearish development. D...
Nadia Simmons | December 3, 2019 |

Beyond Meat, Nikola, Newlox: meat replacement, hydrogen, and green gold

The quest for a better world coupled with economic success motivates investors around the globe to participate in innovation and business ideas. These are often subjects that promote health and protect the environment. Those who think big and plan ahead receive the relevant at...
Mario Hose | September 30, 2020 |

Coverage Initiated on U.S. Biotech with a 'Potential Best-of-Breed Oncolytic Virus'

The investment thesis on this immunotherapies developer is made in an H.C. Wainwright & Co. report. Analyst Ram Selvaraju reported in a July 8 research note that H.C. Wainwright & Co. initiated coverage on Replimune Group Inc. (REPL:NASDAQ) with a Buy ...
Streetwise Reports | July 11, 2019 |

An Emerging Medical Market Play with Great Opportunity

(Image via Bioasis Technologies Inc.) Biopharmaceutical Company Bioasis Technologies Inc. ( TSX-V: BTI , OTCQB: BIOAF , Forum ) is developing its proprietary xB 3TM platform technology to deliver therapeutics across the blood brain barrier (BBB) and int...
Stockhouse Editorial | July 28, 2020 |

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. In a March 18 research note, H.C. Wainwright & Co. analyst Andrew Fein purported that Constellation Pharmaceuticals Inc.'s (CNST:NASDAQ) "strong and balanced pi...
Streetwise Reports | March 25, 2019 |

MOU to Process Glencore's Feedstock 'Positive Step' for Cobalt Firm's Refinery

The terms and implications of the arrangement are reviewed in a Canaccord Genuity report. In a May 21 research note, Canaccord Genuity analyst Eric Zaunscherb reported that First Cobalt Corp. (FCC:TSX.V; FTSSF:OTCQX; FCC:ASX) signed a memorandum of underst...
Streetwise Reports | May 27, 2019 |

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports | July 24, 2019 |
1 2 3 4 5 6 7 8 9 10 ...